NCT00691899 2016-08-12A Study to Assess the Effects of MK0822 in Prolonging Time to First Bone Metastasis in Men With Castration-Resistant Prostate Cancer (0822-030)Merck Sharp & Dohme LLCPhase 3 Withdrawn